Metabolic syndrome (MetS) and associated factors in middle-aged women: a cross-sectional study in Northeast Brazil

Moreira, Mayle Andrade; Vafaei, Afshin; Câmara, Saionara Maria Aires da; Nascimento, Rafaela Andrade do; Morais, M.; Almeida, Maria das Graças; Maciel, Álvaro Campos Cavalcanti

doi:10.1080/03630242.2019.1688445

Cited by 9 publications

(12 citation statements)

References 52 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…e biological diversity of the Latino population leads to changes in the prevalence and development of certain diseases such as metabolic diseases [14]. Several risk factors have been studied; for example, a study in Brazilian women found that anthropometric parameters and estradiol were strongly associated to MetS [15]; however, SUA was not evaluated in that study and could be an important factor to consider. On the contrary, healthcare personnel are important agents of public health and quality of life in communities [16].…”

Section: Introductionmentioning

confidence: 99%

Serum Uric Acid Is Associated with Metabolic Syndrome and Insulin Resistance among Health Personnel from Peru

Galindo-Yllu

Rojas-Humpire

Toro-Huamanchumo

et al. 2021

Journal of Nutrition and Metabolism

View full text Add to dashboard Cite

We explored the association between serum uric acid (SUA) and metabolic syndrome (MetS) and insulin resistance (IR) among health personnel from a public hospital in Peru in a cross-sectional study with data from the Plan for the Prevention and Surveillance of Communicable and Noncommunicable Diseases of Huaycán Hospital. MetS was defined according to Latin American Diabetes Association (ALAD) criteria and IR with surrogate IR markers, triglyceride-to-HDL-C ratio (TG/HDL-C), and triglyceride-to-glucose index (TyG). The association between SUA and MetS and IR was determined using Poisson regression models in a sample of 292 participants with an average age of 46.2 ± 10.6 years. The total prevalence of MetS was 38%, and the individuals with MetS presented mainly alterations in anthropometric parameters (obesity and body fat). Finally, the adjusted regression models showed that women with SUA in the highest tertile increased the prevalence of MetS (PR: 1.71, 95% CI: 1.07–2.74) compared to the lowest tertile of SUA in women, while SUA increased hypertriglyceridemia and IR (TG/HDL-C and TyG) in both sexes. We concluded that SUA is strongly associated with MetS in women, and SUA increases hypertriglyceridemia and IR in both sexes. On the contrary, more research is required regarding the female population.

show abstract

Section: Introductionmentioning

confidence: 99%

Serum Uric Acid Is Associated with Metabolic Syndrome and Insulin Resistance among Health Personnel from Peru

Galindo-Yllu

Rojas-Humpire

Toro-Huamanchumo

et al. 2021

Journal of Nutrition and Metabolism

View full text Add to dashboard Cite

show abstract

“…The characteristics of studies published between 2011 and 2021 on the prevalence of MetS in Brazil are included in Table 1. Most of the studies were performaded in urban populations (6,7,(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36). One study was conducted only on female participants (27).…”

Section: Characteristics Of the Included Studiesmentioning

confidence: 99%

“…Most of the studies were performaded in urban populations (6,7,(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36). One study was conducted only on female participants (27). Eight studies used the NCEP-ATP III criteria for diagnosing metabolic syndrome (27,32,33,(37)(38)(39)(40)(41); three the criteria of the IDF (28,35,36); ten studies used International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesit (IDF/NHLBI/AHA/WHF/IAS/ IASO) (23-25, 29-31, 34, 42-44); two studies used Joint Interim Statement (JIS) criteria for diagnosing (26,45); one study used NCEP ATP III and IDF criteria (7); one study used modi ed NCEP, IDF and JIS criteria for diagnosing MetS (6); one study did not make clear which criteria it used for the diagnosis of MetS (46).…”

Section: Characteristics Of the Included Studiesmentioning

confidence: 99%

Prevalence of Metabolic Syndrome in Brazilian Adults: A Systematic Review and Meta- Analysis of Published Studies

Valadares

Souza

Júnior

et al. 2021

Preprint

View full text Add to dashboard Cite

BackgroundA cluster of interconnected cardiometabolic risk factors characterizes metabolic Syndrome (MetS). The prevalence of MetS is increasing worldwide, but there is not a meta-analysis of this prevalence in the Brazilian population. We aimed to determine the prevalence of metabolic syndrome among adult general population in Brazil through a meta‑analysis study. MethodsOriginal research studies were searched at PubMed, Scopus, Web of Science, and SciELO databases, from 2011 to 2021. We used the Joanna Briggs Institute tool to assess the quality of included studies. The random effect model was used to estimate the pooled prevalence of MetS. Subgroup and meta-regression analysis were conducted for explored heterogeneity and used the Funnel Plot to assess publication bias. The study was performed based on the criteria of Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). ResultsThe search in electronic databases identified 1598 records. From this total, 26 studies were eligible to be included in the final analysis. The overall pooled prevalence among the general population of Brazil was 33% with high heterogeneity observed. By gender, the prevalences were 26% in males and 38% in females. By criteria that was used to define MetS, the prevalence were 31% in NCEP ATP III, 25% in JIS, 37% in IDF/NHLBI/AHA/WHF/IAS/IASO and 33% in IDF criteria. The prevalence in different habitat was 34% in urban, 15% in rural, 28% in quilombola and 37% in indigenous. In different regions was 37% in the South, 30% in Southeast, 38% in North, 31% in Northeast and 39% in Midwest. The pooled prevalence of MetS with age was <45 years: 43% and ≥45 years: 42% and the prevalence based on year of study implementation was 31% in 2015-2019, 35% in 2010-2014 and 28% in 2005-2009. There were no statistically significant differences between subgroups. Most of the studies showed high quality assessment criteria’s except adequate sample size criteria and many studies participants were not sampled in an appropriate way. ConclusionsOur review indicates a high prevalence of MetS in the healthy Brazilian adult population, when compared to others countries and with a world estimate.

show abstract

“…There are still few studies carried out in Brazil 13 on the prevalence of MetS, mainly in the northeastern region, 14 where social inequality is considered to affect access to quality health care, which can increase MetS risks. Understanding how the prevalence of MetS varies among middle-aged and older women of these characteristics is important because this population group is more vulnerable to MetS during the transition period from menopause and aging.…”

Section: Introductionmentioning

confidence: 99%

Metabolic syndrome in middle-aged and older women: A cross-sectional study

Moreira

Câmara

Fernandes

et al. 2022

Womens Health (Lond Engl)

Self Cite

View full text Add to dashboard Cite

Objective: This study aims to compare the prevalence of metabolic syndrome between different age groups of middle-aged and older women and to assess whether these differences are independent of potential covariates. Methods: Study conducted with 510 women divided into three age groups: 45–54, 55–64 and 65–74 years. Socioeconomic, reproductive and lifestyle variables were self-reported. We defined metabolic syndrome using the National Cholesterol Education Program Adult Treatment Panel III criteria (abdominal obesity, diabetes, reduced high-density lipoprotein, elevated triglycerides, and hypertension). Logistic regression assessed the association between age groups, and metabolic syndrome was adjusted for covariates (socioeconomic variables, age at menarche and at first childbirth, parity, menopausal status, physical activity variables and smoking). Results: Women aged 55–64 years presented higher prevalence of all metabolic syndrome criteria than the other groups, except for abdominal obesity, which was higher in the oldest group. In the fully adjusted analysis, the 55–64 years age group continues to exhibit significantly higher odds of presenting metabolic syndrome when compared to the youngest group (45–54 years) (OR = 2.257; 95% CI = 1.20:4.24). There was no statistical difference in the odds of presenting metabolic syndrome when comparing the oldest and the youngest groups (OR = 1.500; 95% CI = 0.85:2.65). Conclusion: The higher prevalence of metabolic syndrome among those aged 55–64 years may indicate that middle-aged women become unhealthy earlier in the life course and that many of them may die prematurely. This result highlights the importance of screening metabolic syndrome earlier in the midlife and the need for public health policies aimed at reducing adverse effects in later years.

show abstract

Metabolic syndrome (MetS) and associated factors in middle-aged women: a cross-sectional study in Northeast Brazil

Cited by 9 publications

References 52 publications

Serum Uric Acid Is Associated with Metabolic Syndrome and Insulin Resistance among Health Personnel from Peru

Serum Uric Acid Is Associated with Metabolic Syndrome and Insulin Resistance among Health Personnel from Peru

Prevalence of Metabolic Syndrome in Brazilian Adults: A Systematic Review and Meta- Analysis of Published Studies

Metabolic syndrome in middle-aged and older women: A cross-sectional study

Contact Info

Product

Resources

About